# Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC

> **NCT04015661** · PHASE2 · UNKNOWN · sponsor: **Fuzhou General Hospital** · enrollment: 92 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Nab-paclitaxel

## Key facts

- **NCT ID:** NCT04015661
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-09
- **Primary completion:** 2020-12-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2019-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04015661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04015661, "Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04015661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*